Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy
- PMID: 19774328
- DOI: 10.1007/s00392-009-0084-3
Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy
Similar articles
-
Many Faces of Fabry's Cardiomyopathy.JACC Cardiovasc Imaging. 2018 Apr;11(4):644-647. doi: 10.1016/j.jcmg.2017.10.018. Epub 2018 Jan 17. JACC Cardiovasc Imaging. 2018. PMID: 29361493 No abstract available.
-
PR interval and the response to enzyme-replacement therapy for Fabry's disease.N Engl J Med. 2003 Mar 20;348(12):1186-7. doi: 10.1056/NEJM200303203481224. N Engl J Med. 2003. PMID: 12646684 No abstract available.
-
Enzyme replacement therapy for Fabry's disease.Lancet. 2010 May 1;375(9725):1523; author reply 1523-4. doi: 10.1016/S0140-6736(10)60653-8. Lancet. 2010. PMID: 20435225 No abstract available.
-
The heart in Anderson Fabry disease.Z Kardiol. 2002 Oct;91(10):786-95. doi: 10.1007/s00392-002-0848-5. Z Kardiol. 2002. PMID: 12395219 Review.
-
Genetics and Gene Therapy of Anderson-Fabry Disease.Curr Gene Ther. 2018;18(2):96-106. doi: 10.2174/1566523218666180404161315. Curr Gene Ther. 2018. PMID: 29618309 Review.
Cited by
-
Progression of electrocardiogram changes in an untreated fabry disease: a case report.Eur Heart J Case Rep. 2021 Feb 20;5(2):ytab045. doi: 10.1093/ehjcr/ytab045. eCollection 2021 Feb. Eur Heart J Case Rep. 2021. PMID: 33738419 Free PMC article.
-
Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.Clin Res Cardiol. 2018 Dec;107(12):1111-1121. doi: 10.1007/s00392-018-1285-4. Epub 2018 May 24. Clin Res Cardiol. 2018. PMID: 29797054 Free PMC article.
-
Deciphering hypertrophic cardiomyopathy with electrocardiography.Heart Fail Rev. 2022 Jul;27(4):1313-1323. doi: 10.1007/s10741-021-10147-0. Epub 2021 Jul 21. Heart Fail Rev. 2022. PMID: 34286451 Review.
-
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.Clin Res Cardiol. 2012 Oct;101(10):805-13. doi: 10.1007/s00392-012-0463-z. Epub 2012 May 15. Clin Res Cardiol. 2012. PMID: 22584381 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical